Home › Companies › Twist Bioscience Corporation › 2025-2026
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and Twist Bioscience Corporation’s Form 8-K, filed February 6, 2026 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of February 5, 2026: 5 items on Twist Bioscience Corporation’s Form 8-K, filed February 6, 2026: 2 approved · 3 passed (calculated).
Notable dissent: 2 directors (19.5%, 15.9% against); 1 say-on-pay vote (76.4% support).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Explore Twist Bioscience Corporation in the interactive database Compare manager voting policies
These tallies are Twist Bioscience Corporation’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed February 6, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Keith Crandell | 40,500,506 | -- | -- | 9,805,197 | 5,954,803 | 81% | Passed (calculated) | — |
| Elect Director: Jan Johannessen | 42,319,597 | -- | -- | 7,986,106 | 5,954,803 | 84% | Passed (calculated) | — |
| Elect Director: Trynka Shineman Blake | 50,217,493 | -- | -- | 88,210 | 5,954,803 | 99.8% | Passed (calculated) | — |
| 2. Non-Binding, Advisory Vote to Approve the Compensation of the Company's Named Executive Officers ("NEOs") | 38,430,673 | 11,842,367 | 32,663 | -- | 5,954,803 | 76% | Approved | — |
| 3. Ratification of Appointment of Independent Registered Accounting Firm | 56,220,551 | 18,170 | 21,785 | -- | -- | 99.9% | Approved | — |
Source: Twist Bioscience Corporation, Form 8-K, filed with the SEC on February 6, 2026 — read the filing on EDGAR.
See voting trends for Health Care companies, 2025-2026: shareholder support by sector and by company size.
278 asset managers disclosed a vote on at least one Twist Bioscience Corporation item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 6 wordings of this item as funds reported it.
84% Majority: yes · of votes cast
Description as filed by funds: Election of Class II Directors: Jan Johannessen
Twist Bioscience Corporation’s own tally for this item (“Elect Director: Jan Johannessen”): 42,319,597 for, 7,986,106 withheld, per its Form 8-K filed February 6, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 84% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 76 asset managers below reported 18,709,055 for, 2,803,500 withheld, 261,295 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ARK ETF Trust | 6,627,917 | 0 | 0 | 0 | For |
| Vanguard | 5,240,051 | 0 | 0 | 550 | For |
| BlackRock | 1,398,072 | 0 | 0 | 0 | For |
| Thrivent | 0 | 0 | 0 | 1,353,808 | Withhold |
| WILLIAM BLAIR FUNDS | 1,163,607 | 0 | 0 | 0 | For |
| Invesco | 799,105 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 693,579 | 0 | 12,039 | 0 | For |
| State Street | 672,251 | 0 | 0 | 705 | For |
| American Century | 0 | 0 | 0 | 664,961 | Withhold |
| Charles Schwab | 546,571 | 0 | 0 | 0 | For |
| Fidelity | 289,094 | 0 | 0 | 0 | For |
| TIAA | 284,199 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 0 | 0 | 191,720 | 0 | Abstain |
| Equitable | 88,180 | 0 | 0 | 44,531 | Mixed |
| AMERICAN BEACON FUNDS | 132,163 | 0 | 0 | 0 | For |
| Allspring | 0 | 0 | 0 | 119,907 | Withhold |
| Victory Capital | 0 | 0 | 0 | 114,743 | Withhold |
| MassMutual | 103,125 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 0 | 0 | 102,155 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 100,823 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 0 | 0 | 0 | 84,583 | Withhold |
| Lincoln Financial | 43,588 | 0 | 0 | 39,033 | Mixed |
| OPTIMUM FUND TRUST | 80,106 | 0 | 0 | 0 | For |
| ARK Venture Fund | 68,679 | 0 | 0 | 0 | For |
| Neuberger Berman | 66,754 | 0 | 0 | 0 | For |
Showing the 25 largest of 76 asset managers. All 76 are in the interactive database (link above).
Combines 6 wordings of this item as funds reported it.
81% Majority: yes · of votes cast
Description as filed by funds: Election of Class II Directors: Keith Crandell
Twist Bioscience Corporation’s own tally for this item (“Elect Director: Keith Crandell”): 40,500,506 for, 9,805,197 withheld, per its Form 8-K filed February 6, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 81% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 76 asset managers below reported 17,756,438 for, 3,755,147 withheld, 262,265 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ARK ETF Trust | 6,627,917 | 0 | 0 | 0 | For |
| Vanguard | 5,240,051 | 0 | 0 | 550 | For |
| BlackRock | 1,398,072 | 0 | 0 | 0 | For |
| Thrivent | 0 | 0 | 0 | 1,353,808 | Withhold |
| WILLIAM BLAIR FUNDS | 1,163,607 | 0 | 0 | 0 | For |
| Invesco | 0 | 0 | 0 | 799,105 | Withhold |
| Bridge Builder Trust | 693,579 | 0 | 12,039 | 0 | For |
| State Street | 672,251 | 0 | 0 | 705 | For |
| American Century | 0 | 0 | 0 | 664,961 | Withhold |
| Charles Schwab | 546,571 | 0 | 0 | 0 | For |
| Fidelity | 289,094 | 0 | 0 | 0 | For |
| TIAA | 284,199 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 0 | 0 | 191,720 | 0 | Abstain |
| Equitable | 88,180 | 0 | 0 | 44,531 | Mixed |
| AMERICAN BEACON FUNDS | 132,163 | 0 | 0 | 0 | For |
| Allspring | 0 | 0 | 0 | 119,907 | Withhold |
| Victory Capital | 0 | 0 | 0 | 114,743 | Withhold |
| MassMutual | 0 | 0 | 0 | 103,125 | Withhold |
| AIG/SunAmerica | 0 | 0 | 0 | 102,155 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 100,823 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 0 | 0 | 0 | 84,583 | Withhold |
| Lincoln Financial | 43,588 | 0 | 0 | 39,033 | Mixed |
| OPTIMUM FUND TRUST | 80,106 | 0 | 0 | 0 | For |
| ARK Venture Fund | 68,679 | 0 | 0 | 0 | For |
| Neuberger Berman | 66,754 | 0 | 0 | 0 | For |
Showing the 25 largest of 76 asset managers. All 76 are in the interactive database (link above).
Combines 6 wordings of this item as funds reported it.
99.8% Majority: yes · of votes cast
Description as filed by funds: Election of Class II Directors: Trynka Shineman Blake
Twist Bioscience Corporation’s own tally for this item (“Elect Director: Trynka Shineman Blake”): 50,217,493 for, 88,210 withheld, per its Form 8-K filed February 6, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.8% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 76 asset managers below reported 21,764,446 for, 9,404 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ARK ETF Trust | 6,627,917 | 0 | 0 | 0 | For |
| Vanguard | 5,240,601 | 0 | 0 | 0 | For |
| BlackRock | 1,398,072 | 0 | 0 | 0 | For |
| Thrivent | 1,353,808 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 1,163,607 | 0 | 0 | 0 | For |
| Invesco | 799,105 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 705,618 | 0 | 0 | 0 | For |
| State Street | 672,956 | 0 | 0 | 0 | For |
| American Century | 664,961 | 0 | 0 | 0 | For |
| Charles Schwab | 546,571 | 0 | 0 | 0 | For |
| Fidelity | 289,094 | 0 | 0 | 0 | For |
| TIAA | 284,199 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 191,720 | 0 | 0 | 0 | For |
| Equitable | 132,711 | 0 | 0 | 0 | For |
| AMERICAN BEACON FUNDS | 132,163 | 0 | 0 | 0 | For |
| Allspring | 119,907 | 0 | 0 | 0 | For |
| Victory Capital | 114,743 | 0 | 0 | 0 | For |
| MassMutual | 103,125 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 102,155 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 100,823 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 84,583 | 0 | 0 | 0 | For |
| Lincoln Financial | 82,621 | 0 | 0 | 0 | For |
| OPTIMUM FUND TRUST | 80,106 | 0 | 0 | 0 | For |
| ARK Venture Fund | 68,679 | 0 | 0 | 0 | For |
| Neuberger Berman | 66,754 | 0 | 0 | 0 | For |
Showing the 25 largest of 76 asset managers. All 76 are in the interactive database (link above).
Combines 9 wordings of this item as funds reported it.
76% Approved · of votes cast
Prior year: 97.6% for (February 4, 2025 meeting) ▼ 21.2 pts
Description as filed by funds: To adopt, on an advisory basis, a resolution approving the compensation of the Company's Named Executive Officers, as described in the Proxy Statement under "Executive Compensation."
Twist Bioscience Corporation’s own tally for this item (“2. Non-Binding, Advisory Vote to Approve the Compensation of the Company's Named Executive Officers ("NEOs")”): 38,430,673 for, 11,842,367 against — passed, per its Form 8-K filed February 6, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal Two — Non-Binding, Advisory Vote to Approve the Compensation of the Company's Named Executive Officers ("NEOs") The Company's stockholders approved, on a non-binding and advisory basis, a resolution approving the compensation of the Company's NEOs, by the following votes:”
Support: 76% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ARK ETF Trust | 6,627,917 | 0 | 0 | 0 | For |
| Vanguard | 2,551,921 | 2,688,679 | 0 | 0 | Mixed |
| BlackRock | 1,398,072 | 0 | 0 | 0 | For |
| Thrivent | 0 | 1,353,808 | 0 | 0 | Against |
| WILLIAM BLAIR FUNDS | 1,163,607 | 0 | 0 | 0 | For |
| Invesco | 0 | 799,105 | 0 | 0 | Against |
| Bridge Builder Trust | 693,579 | 12,039 | 0 | 0 | For |
| State Street | 671,674 | 1,282 | 0 | 0 | For |
| American Century | 0 | 664,961 | 0 | 0 | Against |
| Charles Schwab | 546,571 | 0 | 0 | 0 | For |
| Fidelity | 289,094 | 0 | 0 | 0 | For |
| TIAA | 284,199 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 0 | 191,720 | 0 | 0 | Against |
| Equitable | 88,180 | 44,531 | 0 | 0 | Mixed |
| AMERICAN BEACON FUNDS | 132,163 | 0 | 0 | 0 | For |
| Allspring | 0 | 119,907 | 0 | 0 | Against |
| Victory Capital | 0 | 114,743 | 0 | 0 | Against |
| MassMutual | 0 | 103,125 | 0 | 0 | Against |
| AIG/SunAmerica | 0 | 102,155 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 100,823 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 0 | 84,583 | 0 | 0 | Against |
| Lincoln Financial | 42,300 | 40,321 | 0 | 0 | Mixed |
| OPTIMUM FUND TRUST | 80,106 | 0 | 0 | 0 | For |
| ARK Venture Fund | 68,679 | 0 | 0 | 0 | For |
| Neuberger Berman | 66,754 | 0 | 0 | 0 | For |
Fund voting reports, all 75 managers: 15,075,475 for, 6,688,968 against, 9,404 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 4,562,883 | 0 | 0 | 0 | For |
| Artisan | 4,219,930 | 0 | 0 | 0 | For |
| Amova Asset Management Co., Ltd. | 0 | 1,902,829 | 0 | 0 | Against |
| BlackRock | 1,810,887 | 20,016 | 0 | 0 | For |
| Thrivent | 0 | 1,361,830 | 0 | 0 | Against |
| State Street | 1,275,190 | 9,548 | 0 | 0 | For |
| First Light Asset Management, LLC | 1,131,281 | 0 | 0 | 0 | For |
| Invesco | 0 | 1,066,114 | 0 | 0 | Against |
| BAILLIE GIFFORD & CO LTD | 845,222 | 0 | 0 | 0 | For |
| American Century | 0 | 735,753 | 0 | 0 | Against |
| Freshford Capital Management, LLC | 616,475 | 0 | 0 | 0 | For |
| Charles Schwab | 546,982 | 0 | 0 | 0 | For |
| Vanguard | 447,281 | 58,677 | 0 | 0 | Mixed |
| ARK Investment Management LLC | 458,188 | 0 | 0 | 0 | For |
| Soleus Capital Management, L.P. | 398,064 | 0 | 0 | 0 | For |
| JENNISON ASSOCIATES LLC | 361,935 | 0 | 0 | 0 | For |
| Aberdeen | 308,116 | 0 | 0 | 0 | For |
| Baillie Gifford Investment Management (Europe) Ltd | 293,583 | 0 | 0 | 0 | For |
| Nuveen | 290,556 | 0 | 0 | 0 | For |
| Northern Trust | 263,272 | 12,677 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 257,346 | 0 | 0 | 0 | For |
| OSTERWEIS CAPITAL MANAGEMENT INC | 0 | 254,798 | 0 | 0 | Against |
| Wellington | 248,097 | 0 | 0 | 0 | For |
| JUPITER ASSET MANAGEMENT LTD | 0 | 243,669 | 0 | 0 | Against |
| PICTET ASSET MANAGEMENT SA | 0 | 212,381 | 0 | 0 | Against |
Institutional-manager reports, all 220 managers: 19,747,553 for, 7,993,364 against, 85 abstained, 2,406 not voted. Showing the 25 largest; every one is in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
99.9% Approved · of votes cast
Prior year: 100.0% for (February 4, 2025 meeting) unchanged
Description as filed by funds: TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING SEPTEMBER 30, 2026.
Twist Bioscience Corporation’s own tally for this item (“3. Ratification of Appointment of Independent Registered Accounting Firm”): 56,220,551 for, 18,170 against — passed, per its Form 8-K filed February 6, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal Three — Ratification of Appointment of Independent Registered Accounting Firm The Company's stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered accounting firm for the fiscal year ending September 30, 2026, by the following votes:”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 76 asset managers below reported 21,764,446 for, 9,404 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ARK ETF Trust | 6,627,917 | 0 | 0 | 0 | For |
| Vanguard | 5,240,601 | 0 | 0 | 0 | For |
| BlackRock | 1,398,072 | 0 | 0 | 0 | For |
| Thrivent | 1,353,808 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 1,163,607 | 0 | 0 | 0 | For |
| Invesco | 799,105 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 705,618 | 0 | 0 | 0 | For |
| State Street | 672,956 | 0 | 0 | 0 | For |
| American Century | 664,961 | 0 | 0 | 0 | For |
| Charles Schwab | 546,571 | 0 | 0 | 0 | For |
| Fidelity | 289,094 | 0 | 0 | 0 | For |
| TIAA | 284,199 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 191,720 | 0 | 0 | 0 | For |
| Equitable | 132,711 | 0 | 0 | 0 | For |
| AMERICAN BEACON FUNDS | 132,163 | 0 | 0 | 0 | For |
| Allspring | 119,907 | 0 | 0 | 0 | For |
| Victory Capital | 114,743 | 0 | 0 | 0 | For |
| MassMutual | 103,125 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 102,155 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 100,823 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 84,583 | 0 | 0 | 0 | For |
| Lincoln Financial | 82,621 | 0 | 0 | 0 | For |
| OPTIMUM FUND TRUST | 80,106 | 0 | 0 | 0 | For |
| ARK Venture Fund | 68,679 | 0 | 0 | 0 | For |
| Neuberger Berman | 66,754 | 0 | 0 | 0 | For |
Showing the 25 largest of 76 asset managers. All 76 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 61,311,704 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | ARK ETF Trust | 10.81% |
| 2 | Vanguard | 8.55% |
| 3 | BlackRock | 2.28% |
| 4 | Thrivent | 2.21% |
| 5 | WILLIAM BLAIR FUNDS | 1.90% |
| 6 | Invesco | 1.30% |
| 7 | Bridge Builder Trust | 1.15% |
| 8 | State Street | 1.10% |
| 9 | American Century | 1.08% |
| 10 | Charles Schwab | 0.89% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 7.44% |
| 2 | Artisan | 6.88% |
| 3 | Amova Asset Management Co., Ltd. | 3.10% |
| 4 | BlackRock | 2.99% |
| 5 | Thrivent | 2.22% |
| 6 | State Street | 2.10% |
| 7 | First Light Asset Management, LLC | 1.85% |
| 8 | Invesco | 1.74% |
| 9 | BAILLIE GIFFORD & CO LTD | 1.38% |
| 10 | American Century | 1.20% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| Vanguard Group | 5,776,198 | 9.42% | Form 13F, quarter ended March 31, 2026 |
| BlackRock | 5,554,362 | 9.06% | Form 13F, quarter ended March 31, 2026 |
| Artisan Partners Asset Management Inc. | 4,802,017 | 7.83% | Schedule 13G, filed August 13, 2026 |
| State Street | 3,670,682 | 5.99% | Form 13F, quarter ended March 31, 2026 |
| T. Rowe Price Associates, Inc. | 3,634,470 | 5.93% | Schedule 13G, filed August 14, 2026 |
| ARK Investment Management LLC | 3,385,850 | 5.52% | Schedule 13G, filed September 8, 2026 |
| EdgePoint Investment Group Inc. | 2,521,635 | 4.11% | Schedule 13G, filed August 14, 2026 |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 2,174,594 | 3.55% | Schedule 13G, filed August 11, 2026 |
| Invesco | 2,171,898 | 3.54% | Form 13F, quarter ended March 31, 2026 |
| FMR (Fidelity) | 1,889,945 | 3.08% | Form 13F, quarter ended March 31, 2026 |
Percentages above are of 61,311,704 shares outstanding, as reported by Twist Bioscience Corporation on its Form 10-Q dated January 27, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At Twist Bioscience Corporation's shareholder meeting held February 5, 2026, in the 2025-2026 proxy season, 278 asset managers reported votes on at least one of its 5 ballot items in their SEC Form N-PX filings, covering 1,483 separate fund positions. On the most widely held item on that ballot — To adopt, on an advisory basis, a resolution approving the compensation of the Company's Named… — Twist Bioscience Corporation's filing reports the proposal as approved, with 76% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Twist Bioscience Corporation's Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on February 6, 2026.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Twist Bioscience Corporation’s 10-Q dated January 27, 2026. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
Twist Bioscience Corporation proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).
Proxy Votes Now, “Twist Bioscience (TWST) 2026 Annual Meeting: Shareholder Vote Results”, https://proxyvotesnow.com/company/twist-bioscience-corp/2026 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.